Innovation Pharmaceuticals Inc. (OTCMKTS:IPIX) Short Interest Up 1,168.8% in March

Innovation Pharmaceuticals Inc. (OTCMKTS:IPIX) was the recipient of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 60,900 shares, an increase of 1,168.8% from the February 29th total of 4,800 shares. Based on an average daily volume of 2,262,900 shares, the days-to-cover ratio is presently 0.0 days.

Innovation Pharmaceuticals Price Performance

Innovation Pharmaceuticals stock opened at $0.01 on Friday. Innovation Pharmaceuticals has a 52 week low of $0.00 and a 52 week high of $0.02. The company’s 50-day moving average price is $0.01 and its two-hundred day moving average price is $0.01.

Innovation Pharmaceuticals Company Profile

Innovation Pharmaceuticals Inc, a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19.